Literature DB >> 9134591

Facial-affect recognition and visual scanning behaviour in the course of schizophrenia.

M Streit1, W Wölwer, W Gaebel.   

Abstract

The performance of schizophrenic in-patients in facial expression identification was assessed in an acute phase and in a partly remitted phase of the illness. During visual exploration of the face stimuli, the patient's eye movements were recorded using an infrared-corneal-reflection technique. Compared to healthy controls, patients demonstrated a significant deficit in facial-affect recognition. In addition, schizophrenics differed from controls in several eye movement parameters such as length of mean scan path and mean duration of fixation. Both the facial-affect recognition deficit and the eye movement abnormalities remained stable over time. However, performance in facial-affect recognition and eye movement abnormalities were not correlated. Patients with flattened affect showed relatively selective scan pattern characteristics. In contrast, affective flattening was not correlated with performance in facial-affect recognition. Dosage of neuroleptic medication did not affect the results. The main findings of the study suggest that schizophrenia is associated with disturbances in primarily unrelated neurocognitive operations mediating visuomotor processing and facial expression analysis. Given their time stability, the disturbances might have a trait-like character.

Entities:  

Mesh:

Year:  1997        PMID: 9134591     DOI: 10.1016/s0920-9964(96)00126-0

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  25 in total

1.  Visual exploration of emotional facial expressions in Parkinson's disease.

Authors:  Uraina S Clark; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Neuropsychologia       Date:  2010-03-15       Impact factor: 3.139

Review 2.  Oxytocin and social cognition in affective and psychotic disorders.

Authors:  M Mercedes Perez-Rodriguez; Katie Mahon; Manuela Russo; Allison K Ungar; Katherine E Burdick
Journal:  Eur Neuropsychopharmacol       Date:  2014-08-01       Impact factor: 4.600

Review 3.  Atypical scanpaths in schizophrenia: evidence of a trait- or state-dependent phenomenon?

Authors:  Sara A Beedie; Philip J Benson; David M St Clair
Journal:  J Psychiatry Neurosci       Date:  2011-05       Impact factor: 6.186

4.  Ventromedial frontal lobe damage affects interpretation, not exploration, of emotional facial expressions.

Authors:  Avinash R Vaidya; Lesley K Fellows
Journal:  Cortex       Date:  2019-01-14       Impact factor: 4.027

5.  Symptom domains and neurocognitive functioning can help differentiate social cognitive processes in schizophrenia: a meta-analysis.

Authors:  Joseph Ventura; Rachel C Wood; Gerhard S Hellemann
Journal:  Schizophr Bull       Date:  2011-07-15       Impact factor: 9.306

6.  Exploratory eye movements to pictures in childhood-onset schizophrenia and attention-deficit/hyperactivity disorder (ADHD).

Authors:  C Karatekin; R F Asarnow
Journal:  J Abnorm Child Psychol       Date:  1999-02

7.  Functional significance of preserved affect recognition in schizophrenia.

Authors:  Joanna M Fiszdon; Jason K Johannesen
Journal:  Psychiatry Res       Date:  2010-03-04       Impact factor: 3.222

8.  The categories, frequencies, and stability of idiosyncratic eye-movement patterns to faces.

Authors:  Joseph Arizpe; Vincent Walsh; Galit Yovel; Chris I Baker
Journal:  Vision Res       Date:  2016-12-18       Impact factor: 1.886

9.  Attentional-shaping as a means to improve emotion perception deficits in schizophrenia.

Authors:  Dennis R Combs; Aneta Tosheva; David L Penn; Michael R Basso; Jill L Wanner; Kristen Laib
Journal:  Schizophr Res       Date:  2008-06-27       Impact factor: 4.939

10.  Facial emotion perception in schizophrenia: a meta-analytic review.

Authors:  Christian G Kohler; Jeffrey B Walker; Elizabeth A Martin; Kristin M Healey; Paul J Moberg
Journal:  Schizophr Bull       Date:  2009-03-27       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.